Top Markets
#1 Brevis Brevis +45.04%
#2 Talus Network Talus Network +31.08%
#3 Tung Tung Tung Sahur Tung Tung Tung Sahur +29.84%
#4 Keep Network Keep Network +28.72%
#5 屎壳郎 (Dung Beetle) 屎壳郎 (Dung Beetle) +20.55%
#6 Synapse Synapse +20.47%
#7 Infinity Ground Infinity Ground +20.31%
#8 Cortex Cortex +20.29%
#9 MemeCore MemeCore +17.46%
#10 DeepBook DeepBook +16.58%
Coin of the day
Brevis Brevis
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
IntegraGen SA IntegraGen SA

IntegraGen SA

ALINT
Classificação em ações #19673
IntegraGen SA provides human genome analysis services for academic researcher... IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
Preço da ação
$0.20342561
Valor de mercado
$1.34M
Variação (1 dia)
-1.44%
Variação (1 ano)
-65.74%
País
FR
Negociar IntegraGen SA (ALINT)

Categoria

Healthcare
Rácio P/B de IntegraGen SA (ALINT)
Rácio P/B em July 2026 TTM: -1.30
De acordo com os relatórios financeiros mais recentes e o preço das ações da IntegraGen SA, o rácio P/B atual (TTM) é -1.30. No final de 2023, o rácio P/B era 2.94.
Histórico do rácio P/B da IntegraGen SA de 2008 a 2026
Rácio P/B no final de cada ano
Ano Rácio P/B Alterar
2026 (TTM) -1.30 -159.89%
2024 2.17 -26.23%
2023 2.94 -19.34%
2022 3.64 8.64%
2021 3.35 -46.52%
2020 6.27 140.19%
2019 2.61 1.67%
2018 2.57 -38.19%
2017 4.16 -68.68%
2016 13.27 71.25%
2015 7.75 10.21%
2014 7.03 -74.31%
2013 27.36 207.50%
2012 8.90 -8.80%
2011 9.76 121.29%
2010 4.41 -79.09%
2009 21.08 15.76%
2008 18.21 0.00%
Rácio P/B de empresas semelhantes ou concorrentes
Empresa Rácio P/B Diferença do rácio P/B País
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 6.8826 -629.59%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.5189 -601.61%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.0637 -258.80%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.5808 -452.48%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.7629 -697.33%
NL